Ansun BioPharma Investors

27 investors on Angel Roster list Ansun BioPharma in their portfolio. Most are venture capital firms and funds of funds, the most common stage is Seed and the largest groups are based in China, the United States and Hong Kong.

Investors are matched on the company name in their portfolio, so companies that share the name Ansun BioPharma can appear together.

Investors listed
27
With verified email
33%
Most common stage
Seed
Top location
China

Updated October 13, 2026 · How we compile this data

Top 27 Ansun BioPharma investors

The most complete profiles first. Showing 27 of 27.

  • Eric YUVerified

    Venture Capital, Private Equity Firm, Fund Of Funds · China

    Health CareAutonomous VehiclesTransportationBanking

    Portfolio: Feiyu, Li Auto, vesoft, Datacloak and 80 more

    Verified email available

  • Fei ChenVerified

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • Huadong WangVerified

    Venture Capital, Fund Of Funds · China

    Health CareAutonomous VehiclesTransportationBanking

    Portfolio: Feiyu, Li Auto, vesoft, Datacloak and 80 more

    Verified email available

  • Joy ZhouVerified

    Venture Capital, Fund Of Funds · China

    Health CareAutonomous VehiclesTransportationBanking

    Portfolio: Feiyu, Li Auto, vesoft, Datacloak and 80 more

    Verified email available

  • Judith LiVerified

    Venture Capital · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Verified email available

  • Min XiaoVerified

    Venture Capital, Fund Of Funds · China

    Health CareAutonomous VehiclesTransportationBanking

    Portfolio: Feiyu, Li Auto, vesoft, Datacloak and 80 more

    Verified email available

  • Sean LinVerified

    Venture Capital · China

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Verified email available

  • Stella WangVerified

    Venture Capital, Fund Of Funds · China

    Health CareAutonomous VehiclesTransportationBanking

    Portfolio: Feiyu, Li Auto, vesoft, Datacloak and 80 more

    Verified email available

  • Yao HoVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Verified email available

  • Yi ShiVerified

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Verified email available

  • Francine Fang

    Venture Capital, Investor · China

    SeedHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: Subtle Medical, Cytek Biosciences, Refuge Biotechnologies, Ansun BioPharma and 14 more

    Contact details available

  • Joy Y.

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: Subtle Medical, Cytek Biosciences, Refuge Biotechnologies, Ansun BioPharma and 14 more

    Contact details available

  • Chen Long William

    Venture Capital, Private Equity Firm · China

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Contact details available

  • Chris Feng

    Venture Capital, Fund Of Funds · China

    Health CareAutonomous VehiclesTransportationBanking

    Portfolio: Feiyu, Li Auto, vesoft, Datacloak and 80 more

    Contact details available

  • Derek Yuan, Ph.D.

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Contact details available

  • Harry Man

    Venture Capital, Fund Of Funds · China

    Health CareAutonomous VehiclesTransportationBanking

    Portfolio: Feiyu, Li Auto, vesoft, Datacloak and 80 more

    Contact details available

  • James Zhao

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsTrading PlatformLife Science

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Contact details available

  • Jieyu Zou

    Venture Capital · China

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • Jing Xu, Ph.D

    Venture Capital, Private Equity Firm · Singapore

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Contact details available

  • Keting Chu

    Venture Capital · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Contact details available

  • Kevin Xiong 熊飞

    Venture Capital, Private Equity Firm, Fund Of Funds · China

    Health CareAutonomous VehiclesTransportationBanking

    Portfolio: Feiyu, Li Auto, vesoft, Datacloak and 80 more

    Contact details available

  • Leona Hu

    Venture Capital, Fund Of Funds · China

    Health CareAutonomous VehiclesTransportationBanking

    Portfolio: Feiyu, Li Auto, vesoft, Datacloak and 80 more

    Contact details available

  • Ling Su

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • Lixiong Niu

    Venture Capital, Fund Of Funds · China

    Health CareAutonomous VehiclesTransportationBanking

    Portfolio: Feiyu, Li Auto, vesoft, Datacloak and 80 more

    Contact details available

  • Michael Zuo

    Venture Capital, Fund Of Funds · China

    Health CareAutonomous VehiclesTransportationBanking

    Portfolio: Feiyu, Li Auto, vesoft, Datacloak and 80 more

    Contact details available

  • Yuzhou Hu

    Venture Capital, Private Equity Firm, Fund Of Funds · China

    Health CareAutonomous VehiclesTransportationBanking

    Portfolio: Feiyu, Li Auto, vesoft, Datacloak and 80 more

    Contact details available

  • Zoe Ding

    Venture Capital · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Ansun BioPharma investors are on Angel Roster?

Angel Roster lists 27 Ansun BioPharma investors. 9 of them (33%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (27), Funds of Funds (12) and Private Equity Firms (8). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Ansun BioPharma investors invest in?

Among those that list a stage, the most common are Seed (2).

Where are Ansun BioPharma investors based?

Most are based in China (19), the United States (6) and Hong Kong (1).

Which companies have Ansun BioPharma investors backed?

The most-backed portfolio companies among them are NiKang Therapeutics (17), Peijia Medical (17), NovoCodex (17), InventisBio (17) and Qihan Biotech (17).

How do I contact Ansun BioPharma investors?

Create a free Angel Roster account to search and filter all 27, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.